MCRB Q1 2026 Earnings EPS Misses Estimates Stock Declines 417 UTHR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain MNSBP Q1 2026 Earnings EPS Surges Past Estimates by Over 24 Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges MGYR Q4 2025 Earnings EPS of 040 Reported Stock Unchanged ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent